Orbimed Advisors - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 39 filers reported holding PYXIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q4 2022$1,136,658
-32.0%
848,2520.0%0.02%
-29.0%
Q3 2022$1,671,000
+188.1%
848,252
+490.5%
0.03%
+244.4%
Q1 2022$580,000
-63.2%
143,6400.0%0.01%
-55.0%
Q4 2021$1,576,000143,6400.02%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders